Mutations and deletions in DPC4 (deleted in pancreatic carcinoma, locus 4), LKB1 (liver kinase B1), and INK4a (inhibitor of kinase 4a) are identified in 95% of pancreatic cancer cases. This evidence concerns the gene CDKN2A and familial pancreatic carcinoma.